These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22285146)

  • 1. Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.
    de Lédinghen V; Vergniol J; Gonzalez C; Foucher J; Maury E; Chemineau L; Villars S; Gin H; Rigalleau V
    Dig Liver Dis; 2012 May; 44(5):413-8. PubMed ID: 22285146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
    Ratziu V; Massard J; Charlotte F; Messous D; Imbert-Bismut F; Bonyhay L; Tahiri M; Munteanu M; Thabut D; Cadranel JF; Le Bail B; de Ledinghen V; Poynard T; ;
    BMC Gastroenterol; 2006 Feb; 6():6. PubMed ID: 16503961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest).
    Poynard T; Lebray P; Ingiliz P; Varaut A; Varsat B; Ngo Y; Norha P; Munteanu M; Drane F; Messous D; Bismut FI; Carrau JP; Massard J; Ratziu V; Giordanella JP
    BMC Gastroenterol; 2010 Apr; 10():40. PubMed ID: 20412588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.
    Ngo Y; Munteanu M; Messous D; Charlotte F; Imbert-Bismut F; Thabut D; Lebray P; Thibault V; Benhamou Y; Moussalli J; Ratziu V; Poynard T
    Clin Chem; 2006 Oct; 52(10):1887-96. PubMed ID: 16931569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.
    Morali G; Maor Y; Klar R; Braun M; Ben Ari Z; Bujanover Y; Zuckerman E; Boger S; Halfon P
    Isr Med Assoc J; 2007 Aug; 9(8):588-91. PubMed ID: 17877064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation.
    Elalfy MS; Esmat G; Matter RM; Abdel Aziz HE; Massoud WA
    Ann Hepatol; 2013; 12(1):54-61. PubMed ID: 23293194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.
    Poynard T; Munteanu M; Deckmyn O; Ngo Y; Drane F; Castille JM; Housset C; Ratziu V; Imbert-Bismut F
    J Hepatol; 2012 Sep; 57(3):541-8. PubMed ID: 22612998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
    Imbert-Bismut F; Ratziu V; Pieroni L; Charlotte F; Benhamou Y; Poynard T;
    Lancet; 2001 Apr; 357(9262):1069-75. PubMed ID: 11297957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease.
    Naveau S; Essoh BM; Ghinoiu M; Marthey L; Njiké-Nakseu M; Balian A; Lachgar M; Prévot S; Perlemuter G
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):404-11. PubMed ID: 24561990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.
    de Lédinghen V; Le Bail B; Rebouissoux L; Fournier C; Foucher J; Miette V; Castéra L; Sandrin L; Merrouche W; Lavrand F; Lamireau T
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):443-50. PubMed ID: 18030211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.
    Salkic NN; Jovanovic P; Hauser G; Brcic M
    Am J Gastroenterol; 2014 Jun; 109(6):796-809. PubMed ID: 24535095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
    Imbert-Bismut F; Messous D; Thibault V; Myers RB; Piton A; Thabut D; Devers L; Hainque B; Mercadier A; Poynard T
    Clin Chem Lab Med; 2004 Mar; 42(3):323-33. PubMed ID: 15080567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.
    Jacqueminet S; Lebray P; Morra R; Munteanu M; Devers L; Messous D; Bernard M; Hartemann-Heurtier A; Imbert-Bismut F; Ratziu V; Grimaldi A; Poynard T
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):828-31. PubMed ID: 18524692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.
    Cassinotto C; Lapuyade B; Mouries A; Hiriart JB; Vergniol J; Gaye D; Castain C; Le Bail B; Chermak F; Foucher J; Laurent F; Montaudon M; De Ledinghen V
    J Hepatol; 2014 Sep; 61(3):550-7. PubMed ID: 24815876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
    Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
    Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
    Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
    Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
    Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
    Berends MA; Snoek J; de Jong EM; Van Krieken JH; de Knegt RJ; van Oijen MG; van de Kerkhof PC; Drenth JP
    Liver Int; 2007 Jun; 27(5):639-45. PubMed ID: 17498249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.